The oral controlled absorption system (OCAS®):: The evolution of tamsulosin for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

被引：4

作者：

Chapple, CR ^{[1
]}

机构：

[1] Royal Hallamshire Hosp, Dept Urol, Sheffield Teaching Hosp, NHS Trust, Sheffield S10 2JF, S Yorkshire, England

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 07期

关键词：

tamsulosin; oral controlled absorption system; review; pharmacokinetics; modified release formulation; efficacy; safety; orthostatic hypotension; nocturia;

D O I：

10.1016/j.eursup.2005.07.006

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：20 / 22

页数：3

共 17 条

[1] Aua guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations [J].

JOURNAL OF UROLOGY, 2003, 170 (02) :530-547

[2] Night time symptom control with omnic (tamsulosin) oral controlled absorption system (OCAS®) [J].

Chapple, CR .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :14-16

[3] The development of the oral controlled absorption system (OCAS®):: A new improved formulation of tamsulosin [J].

Chapple, CR .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :1-4

[4] Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: Efficacy and tolerability in a placebo and active comparator controlled phase 3a study [J].

Chapple, CR ;

Al-Shukri, SH ;

Gattegno, B ;

Holmes, S ;

Martínez-Sagarra, JM ;

Scarpa, RM ;

Trip, OBV ;

Vik, V ;

van der Putten-Slob, I .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :33-44

[5] Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Efficacy and tolerability in a phase 2b dose-response study [J].

Chapple, CR ;

Lorenz, J ;

Mortensen, R ;

Pauthner, H ;

Reise, MO ;

Schulman, CC ;

van der Putten-Slob, I .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :25-32

[6] The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: Preliminary results of a pilot study [J].

Djavan, B ;

Milani, S ;

Davies, J ;

Bolodeoku, J .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :61-68

[7] State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia [J].

Djavan, B ;

Chapple, C ;

Milani, S ;

Marberger, M .

UROLOGY, 2004, 64 (06) :1081-1088

[8]

Farmer R., 2004, European Urology Supplements, V3, P60, DOI 10.1016/S1569-9056(04)90231-X

[9] The improved cardiovascular safety of omnic (tamsulosin) oral controlled absorption system (OCAS®) [J].

Korstanje, C .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :10-13

[10] Tamsulosin - An update of its role in the management of lower urinary tract symptoms [J].

Lyseng-Williamson, KA ;

Jarvis, B ;

Wagstaff, AJ .

DRUGS, 2002, 62 (01) :135-167

← 1 2 →